Health Condition 1: R50-R69- General symptoms and signs
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects aged 18yrs to 60 years of both gender would be enrolled in the study. 2. Subjects presenting with symptomatic indications ascribed to the preidentified medicines. 3.Subjects who have not taken any medication for the past one week except on regular medication of Hypertension and Diabetes. 4.Subjects who have given the written informed consent.
Exclusion criteria
Exclusion criteria: 1.Subjects presenting with symptoms indicating prescription other than the preidentified medicines. 2. Subjects undergoing treatment (Ayurvedic, Homoeopathic, herbal, surgery etc.) which is likely to interfere in the course of this treatment. 3.Suffering from life-threatening disease/systemic illness (tuberculosis, cancer, AIDS, cardiovascular disorders etc.) 4. Pregnant/lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Modified Naranjo criteria to be assessed at the end of every month or /can be assessed earlier if the recovery is established with score more than or equal to 6.Timepoint: At the end of every month | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of the patient using MYMOP scale at entry & Fortnightly. Assessment of the patient using ORIDL scale fortnightly. Assessment of the symptoms relieved during treatment by medicines prepared using new method & old method fortnightly. Timepoint: MYMOP- At Baseline & at every fortnight. ORIDL- At every fortnight | — |
Countries
India
Contacts
Central Council for Research in Homoeopathy